Fused pyrazolyl compounds for the treatment of cancer

摘要

Disclosed is a use of a compound of formula (I) for the manufacture of a medicament for treating leukaemia or breast cancer: wherein each of Ar1, Ar2 and Ar3 independently, is phenyl, thienyl, furyl, pyrrolyl, pyridinyl, or pyrimidinyl; each of R1, R2, R3, R4, R5, and R6, independently, is H, nitro, halogen, or a defined in the specification; and n is 0, 1, 2, or 3.